Document Classification

Section Type: METHODS

Text: In a randomized, open-label study conducted in Germany over seven cycles, healthy women aged 18-50 years received E (2) V/DNG (E (2) V 3mg on days 1-2, E (2) V 2mg/DNG 2mg on days 3-7, E (2) V 2mg/DNG 3mg on days 8-24, E (2) V 1mg on days 25-26, placebo on days 27-28 ; n = 30) or EE/LNG (EE 0. 03 mg/LNG 0. 05 mg on days 1-6, EE 0. 04 mg/LNG 0. 075 mg on days 7-11, EE 0. 03 mg/LNG 0. 125 mg on days 12-21, placebo on days 22-28 ; n = 28).